Drugmakers File New Appeal Briefs in Push to Overturn 340B Rebate Ruling

Drugmakers filed new briefs in their pending 340B rebate cases before the D.C. Circuit Court of Appeals
Four large drugmakers recently filed a pair of new briefs in their ongoing appeals of legal rulings that upheld the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Sues Hawaii Over New 340B Contract Pharmacy Access Law

PhRMA sued to block Hawaii's new 340B contract pharmacy access law in a federal district court in Honolulu.
A major brand-name drug industry trade group has sued Hawaii over its new law prohibiting pharmaceutical manufacturers from restricting 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon, AbbVie Exempt New States From 340B Contract Pharmacy Restrictions

Organon announced 340B contract pharmacy restriction exemptions for covered entities in South Dakota, Hawaii, North Dakota and Colorado on July 14.
Two major drugmakers are exempting additional states from their 340B contract pharmacy restrictions due to new contract pharmacy access laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Mike Fish, Senior Vice President of Client Success, Pillr Health

Mike Fish

Q: Where did you grow up?

I grew up in Argyle, NY, a small rural community in upstate New York. When I say small, picture the graduating class being 39 students! And the cows outnumber the people by a large margin.

Q: Where did you go to college/graduate school?

Albany College of Pharmacy and Health Sciences

Read More »

In High-Stakes Meetings, 340B Stakeholders Push to Sway HHS’ Rebate Guidance Ahead of Release

More than a dozen stakeholder groups haver recently met with federal officials about HHS' highly-anticipated 340B rebate guidance.
In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court Allows HHS Reorganization and Layoffs to Continue, Effect on 340B Oversight Unclear

The U.S. Supreme Court this week greenlit the Trump administration’s plans for massive layoffs and a reorganization at HHS—for now.
The U.S. Supreme Court this week greenlit the Trump administration’s plans for massive layoffs and a reorganization at the U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Part 3 of a 4-Part Series: Is In-House Pharmacy Capture the Overlooked Strategy to Growing Your 340B Program?

SPONSORED CONTENT

The 340B program is facing a period of unprecedented change. With the Inflation Reduction Act (IRA) and Medicare’s Maximum Fair Price (MFP) provisions set to take effect in 2026, covered entities can expect significant shifts—most notably, reduced drug reimbursement and

Read More »

Griffith Named U.S. House E&C Committee’s Health Subcommittee Chair, 340B Critic Harshbarger Elevated to Vice Chair

U.S. Rep. Morgan Griffith (R-Va.) will take over as chairman of the House E&C Health Subcommittee, while U.S. Rep Diana Harshbarger (R-Tenn.) will become the panel’s new vice chair.
A Virginia Republican is set to replace longtime 340B critic U.S. Rep. Earl “Buddy” Carter (R-Ga.) as the chair of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Oregon Law Lets Health Centers Report 340B Claims Through Clearinghouse Instead of PBMs

A new Oregon law grants certain covered entities new flexibility in how they report 340B claims involving PBMs.
Oregon has enacted a new law granting health centers and certain grantees more flexibility in how they report 340B claims [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

AbbVie was among five drugmakers to announce new state exemptions to their 340B contract pharmacy restrictions in early July.
Five major drugmakers recently announced new contract pharmacy restriction exemptions for 340B covered entities located in South Dakota and other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live